Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia.

Kirk P, Sheppard M, Carpenter JP, Anderson L, He T, St Pierre T, Galanello R, Catani G, Wood J, Fucharoen S, Porter JB, Walker JM, Forni GL, Pennell DJ.

J Cardiovasc Magn Reson. 2017 Mar 27;19(1):36. doi: 10.1186/s12968-017-0349-3.

2.

Deferiprone-induced agranulocytosis: 20 years of clinical observations.

Tricta F, Uetrecht J, Galanello R, Connelly J, Rozova A, Spino M, Palmblad J.

Am J Hematol. 2016 Oct;91(10):1026-31. doi: 10.1002/ajh.24479. Epub 2016 Aug 4.

3.

Development of a new disease severity scoring system for patients with non-transfusion-dependent thalassemia.

Cappellini MD, Porter JB, Musallam KM, Kattamis A, Viprakasit V, Galanello R, Taher AT.

Eur J Intern Med. 2016 Mar;28:91-6. doi: 10.1016/j.ejim.2015.10.003.

PMID:
26545830
4.

Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.

de Swart L, Hendriks JC, van der Vorm LN, Cabantchik ZI, Evans PJ, Hod EA, Brittenham GM, Furman Y, Wojczyk B, Janssen MC, Porter JB, Mattijssen VE, Biemond BJ, MacKenzie MA, Origa R, Galanello R, Hider RC, Swinkels DW.

Haematologica. 2016 Jan;101(1):38-45. doi: 10.3324/haematol.2015.133983. Epub 2015 Sep 18.

5.

Genome-wide association analyses based on whole-genome sequencing in Sardinia provide insights into regulation of hemoglobin levels.

Danjou F, Zoledziewska M, Sidore C, Steri M, Busonero F, Maschio A, Mulas A, Perseu L, Barella S, Porcu E, Pistis G, Pitzalis M, Pala M, Menzel S, Metrustry S, Spector TD, Leoni L, Angius A, Uda M, Moi P, Thein SL, Galanello R, Abecasis GR, Schlessinger D, Sanna S, Cucca F.

Nat Genet. 2015 Nov;47(11):1264-71. doi: 10.1038/ng.3307. Epub 2015 Sep 14.

6.

IFNL3 polymorphisms and HCV infection in patients with beta thalassemia.

Origa R, Marceddu G, Danjou F, Perseu L, Satta S, Demartis FR, Piga A, Longo F, Lai ME, Vacquer S, Galanello R.

Ann Hepatol. 2015 May-Jun;14(3):389-95.

7.

EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies.

Traeger-Synodinos J, Harteveld CL, Old JM, Petrou M, Galanello R, Giordano P, Angastioniotis M, De la Salle B, Henderson S, May A.

Eur J Hum Genet. 2015 Apr;23(4):560. doi: 10.1038/ejhg.2015.39. No abstract available.

8.

Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia.

Origa R, Cazzola M, Mereu E, Danjou F, Barella S, Giagu N, Galanello R, Swinkels DW.

Haematologica. 2015 May;100(5):e169-71. doi: 10.3324/haematol.2014.115733. Epub 2015 Jan 16. No abstract available.

9.

A genetic score for the prediction of beta-thalassemia severity.

Danjou F, Francavilla M, Anni F, Satta S, Demartis FR, Perseu L, Manca M, Sollaino MC, Manunza L, Mereu E, Marceddu G, Pissard S, Joly P, Thuret I, Origa R, Borg J, Forni GL, Piga A, Lai ME, Badens C, Moi P, Galanello R.

Haematologica. 2015 Apr;100(4):452-7. doi: 10.3324/haematol.2014.113886. Epub 2014 Dec 5.

10.

EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies.

Traeger-Synodinos J, Harteveld CL, Old JM, Petrou M, Galanello R, Giordano P, Angastioniotis M, De la Salle B, Henderson S, May A; EMQN haemoglobinopathies best practice meeting.

Eur J Hum Genet. 2015 Apr;23(4):426-37. doi: 10.1038/ejhg.2014.131. Epub 2014 Jul 23. Erratum in: Eur J Hum Genet. 2015 Apr;23(4):560.

11.

Prevention of Thalassaemias and Other Haemoglobin Disorders: Volume 2: Laboratory Protocols [Internet].

Old J, Harteveld CL, Traeger-Synodinos J, Petrou M, Angastiniotis M, Galanello R.

2nd edition. Nicosia, Cyprus: Thalassaemia International Federation; 2012.

12.

Prevention of Thalassaemias and Other Haemoglobin Disorders: Volume 1: Principles [Internet].

Angastiniotis M, Eleftheriou A, Galanello R, Harteveld CL, Petrou M, Traeger-Synodinos J, Giordano P, Jauniaux E, Modell B, Serour G; Old J, editor.

2nd edition. Nicosia, Cyprus: Thalassaemia International Federation; 2013.

13.

Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up.

Cossu G, Abbruzzese G, Matta G, Murgia D, Melis M, Ricchi V, Galanello R, Barella S, Origa R, Balocco M, Pelosin E, Marchese R, Ruffinengo U, Forni GL.

Parkinsonism Relat Disord. 2014 Jun;20(6):651-4. doi: 10.1016/j.parkreldis.2014.03.002. Epub 2014 Mar 12.

PMID:
24661465
14.

A decisional algorithm to start iron chelation in patients with beta thalassemia.

Danjou F, Cabantchik ZI, Origa R, Moi P, Marcias M, Barella S, Defraia E, Dessì C, Foschini ML, Giagu N, Leoni GB, Morittu M, Galanello R.

Haematologica. 2014 Mar;99(3):e38-40. doi: 10.3324/haematol.2013.098202. No abstract available.

15.

Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion.

Veríssimo MP, Loggetto SR, Fabron Junior A, Baldanzi GR, Hamerschlak N, Fernandes JL, Araujo Ada S, Lobo CL, Fertrin KY, Berdoukas VA, Galanello R.

Rev Bras Hematol Hemoter. 2013;35(6):428-34. doi: 10.5581/1516-8484.20130106.

16.

α-globin gene quadruplication and heterozygous β-thalassemia: a not so rare cause of thalassemia intermedia.

Origa R, Sollaino MC, Borgna-Pignatti C, Piga A, Feliu Torres A, Masile V, Galanello R.

Acta Haematol. 2014;131(3):162-4. doi: 10.1159/000353410. Epub 2013 Nov 6. No abstract available.

PMID:
24217654
17.

Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal study.

Derchi G, Galanello R, Bina P, Cappellini MD, Piga A, Lai ME, Quarta A, Casu G, Perrotta S, Pinto V, Musallam KM, Forni GL; Webthal Pulmonary Arterial Hypertension Group*.

Circulation. 2014 Jan 21;129(3):338-45. doi: 10.1161/CIRCULATIONAHA.113.002124. Epub 2013 Sep 30.

PMID:
24081970
18.

Impact of heart magnetic resonance imaging on chelation choices, compliance with treatment and risk of heart disease in patients with thalassaemia major.

Origa R, Danjou F, Cossa S, Matta G, Bina P, Dessì C, Defraia E, Foschini ML, Leoni G, Morittu M, Galanello R.

Br J Haematol. 2013 Nov;163(3):400-3. doi: 10.1111/bjh.12517. Epub 2013 Aug 16.

PMID:
24033185
19.

Complexity of the alpha-globin genotypes identified with thalassemia screening in Sardinia.

Origa R, Paglietti ME, Sollaino MC, Desogus MF, Barella S, Loi D, Galanello R.

Blood Cells Mol Dis. 2014 Jan;52(1):46-9. doi: 10.1016/j.bcmd.2013.06.004. Epub 2013 Jul 27.

PMID:
23896219
20.

In vivo activation of the human δ-globin gene: the therapeutic potential in β-thalassemic mice.

Manchinu MF, Marongiu MF, Poddie D, Casu C, Latini V, Simbula M, Galanello R, Moi P, Cao A, Porcu S, Ristaldi MS.

Haematologica. 2014 Jan;99(1):76-84. doi: 10.3324/haematol.2012.082768. Epub 2013 Jul 19.

21.

Longitudinal analysis of heart and liver iron in thalassemia major patients according to chelation treatment.

Danjou F, Origa R, Anni F, Saba L, Cossa S, Podda G, Galanello R.

Blood Cells Mol Dis. 2013 Oct;51(3):142-5. doi: 10.1016/j.bcmd.2013.06.001. Epub 2013 Jun 28.

PMID:
23816436
22.

Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study.

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhu Z, Cappellini MD.

Ann Hematol. 2013 Nov;92(11):1485-93. doi: 10.1007/s00277-013-1808-z. Epub 2013 Jun 18.

23.

Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association.

Pennell DJ, Udelson JE, Arai AE, Bozkurt B, Cohen AR, Galanello R, Hoffman TM, Kiernan MS, Lerakis S, Piga A, Porter JB, Walker JM, Wood J; American Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology and Council on Cardiovascular Radiology and Imaging.

Circulation. 2013 Jul 16;128(3):281-308. doi: 10.1161/CIR.0b013e31829b2be6. Epub 2013 Jun 17. Erratum in: Circulation. 2013 Sep 24;128(13):e203.

PMID:
23775258
24.

Assessment and management of iron overload in β-thalassaemia major patients during the 21st century: a real-life experience from the Italian WEBTHAL project.

Piga A, Longo F, Musallam KM, Cappellini MD, Forni GL, Quarta G, Chiavilli F, Commendatore F, Mulas S, Caruso V, Galanello R.

Br J Haematol. 2013 Jun;161(6):872-83. doi: 10.1111/bjh.12340. Epub 2013 Apr 18.

PMID:
23600689
25.

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients.

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Am J Hematol. 2013 Jun;88(6):503-6. doi: 10.1002/ajh.23445. Epub 2013 May 13.

26.

Natural history of hepatitis C in thalassemia major: a long-term prospective study.

Lai ME, Origa R, Danjou F, Leoni GB, Vacquer S, Anni F, Corrias C, Farci P, Congiu G, Galanello R.

Eur J Haematol. 2013 Jun;90(6):501-7. doi: 10.1111/ejh.12086. Epub 2013 Mar 14.

PMID:
23414443
27.

Seventy-five genetic loci influencing the human red blood cell.

van der Harst P, Zhang W, Mateo Leach I, Rendon A, Verweij N, Sehmi J, Paul DS, Elling U, Allayee H, Li X, Radhakrishnan A, Tan ST, Voss K, Weichenberger CX, Albers CA, Al-Hussani A, Asselbergs FW, Ciullo M, Danjou F, Dina C, Esko T, Evans DM, Franke L, Gögele M, Hartiala J, Hersch M, Holm H, Hottenga JJ, Kanoni S, Kleber ME, Lagou V, Langenberg C, Lopez LM, Lyytikäinen LP, Melander O, Murgia F, Nolte IM, O'Reilly PF, Padmanabhan S, Parsa A, Pirastu N, Porcu E, Portas L, Prokopenko I, Ried JS, Shin SY, Tang CS, Teumer A, Traglia M, Ulivi S, Westra HJ, Yang J, Zhao JH, Anni F, Abdellaoui A, Attwood A, Balkau B, Bandinelli S, Bastardot F, Benyamin B, Boehm BO, Cookson WO, Das D, de Bakker PI, de Boer RA, de Geus EJ, de Moor MH, Dimitriou M, Domingues FS, Döring A, Engström G, Eyjolfsson GI, Ferrucci L, Fischer K, Galanello R, Garner SF, Genser B, Gibson QD, Girotto G, Gudbjartsson DF, Harris SE, Hartikainen AL, Hastie CE, Hedblad B, Illig T, Jolley J, Kähönen M, Kema IP, Kemp JP, Liang L, Lloyd-Jones H, Loos RJ, Meacham S, Medland SE, Meisinger C, Memari Y, Mihailov E, Miller K, Moffatt MF, Nauck M, Novatchkova M, Nutile T, Olafsson I, Onundarson PT, Parracciani D, Penninx BW, Perseu L, Piga A, Pistis G, Pouta A, Puc U, Raitakari O, Ring SM, Robino A, Ruggiero D, Ruokonen A, Saint-Pierre A, Sala C, Salumets A, Sambrook J, Schepers H, Schmidt CO, Silljé HH, Sladek R, Smit JH, Starr JM, Stephens J, Sulem P, Tanaka T, Thorsteinsdottir U, Tragante V, van Gilst WH, van Pelt LJ, van Veldhuisen DJ, Völker U, Whitfield JB, Willemsen G, Winkelmann BR, Wirnsberger G, Algra A, Cucca F, d'Adamo AP, Danesh J, Deary IJ, Dominiczak AF, Elliott P, Fortina P, Froguel P, Gasparini P, Greinacher A, Hazen SL, Jarvelin MR, Khaw KT, Lehtimäki T, Maerz W, Martin NG, Metspalu A, Mitchell BD, Montgomery GW, Moore C, Navis G, Pirastu M, Pramstaller PP, Ramirez-Solis R, Schadt E, Scott J, Shuldiner AR, Smith GD, Smith JG, Snieder H, Sorice R, Spector TD, Stefansson K, Stumvoll M, Tang WH, Toniolo D, Tönjes A, Visscher PM, Vollenweider P, Wareham NJ, Wolffenbuttel BH, Boomsma DI, Beckmann JS, Dedoussis GV, Deloukas P, Ferreira MA, Sanna S, Uda M, Hicks AA, Penninger JM, Gieger C, Kooner JS, Ouwehand WH, Soranzo N, Chambers JC.

Nature. 2012 Dec 20;492(7429):369-75. doi: 10.1038/nature11677. Epub 2012 Dec 5.

28.

Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine.

Grady RW, Galanello R, Randolph RE, Kleinert DA, Dessi C, Giardina PJ.

Haematologica. 2013 Jan;98(1):129-35. doi: 10.3324/haematol.2012.070607. Epub 2012 Aug 8.

29.

Renal aspects of thalassaemia a changing paradigm.

Bhandari S, Galanello R.

Eur J Haematol. 2012 Sep;89(3):187-97. doi: 10.1111/j.1600-0609.2012.01819.x. Epub 2012 Jul 21. Review.

PMID:
22687050
30.

Recent advances in the molecular understanding of non-transfusion-dependent thalassemia.

Galanello R.

Blood Rev. 2012 Apr;26 Suppl 1:S7-S11. doi: 10.1016/S0268-960X(12)70004-8. Review.

PMID:
22631043
31.

Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study.

Taher AT, Porter J, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Ros J, Zhang Y, Habr D, Cappellini MD.

Blood. 2012 Aug 2;120(5):970-7. doi: 10.1182/blood-2012-02-412692. Epub 2012 May 15.

32.

First detection of Hb Taybe [α38(C3) or α39(C4) Thr→0 (α1)] in an Italian child.

Paglietti ME, Sollaino MC, Loi D, Barella S, Desogus MF, Galanello R.

Hemoglobin. 2012;36(3):299-304. doi: 10.3109/03630269.2012.659780. Epub 2012 Mar 19.

PMID:
22428534
33.

Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major.

Alpendurada F, Smith GC, Carpenter JP, Nair SV, Tanner MA, Banya W, Dessi C, Galanello R, Walker JM, Pennell DJ.

J Cardiovasc Magn Reson. 2012 Jan 25;14:8. doi: 10.1186/1532-429X-14-8.

34.

Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion.

Danjou F, Anni F, Perseu L, Satta S, Dessì C, Lai ME, Fortina P, Devoto M, Galanello R.

Haematologica. 2012 Jul;97(7):989-93. doi: 10.3324/haematol.2011.053504. Epub 2012 Jan 22.

35.

A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload.

Neufeld EJ, Galanello R, Viprakasit V, Aydinok Y, Piga A, Harmatz P, Forni GL, Shah FT, Grace RF, Porter JB, Wood JC, Peppe J, Jones A, Rienhoff HY Jr.

Blood. 2012 Apr 5;119(14):3263-8. doi: 10.1182/blood-2011-10-386268. Epub 2012 Jan 17.

36.

Relationship between neonatal screening results by HPLC and the number of α-thalassaemia gene mutations; consequences for the cut-off value.

Bouva MJ, Sollaino C, Perseu L, Galanello R, Giordano PC, Harteveld CL, Cnossen MH, Schielen PC, Elvers LH, Peters M.

J Med Screen. 2011;18(4):182-6. doi: 10.1258/jms.2011.011043.

PMID:
22184733
37.

Deferasirox: pharmacokinetics and clinical experience.

Galanello R, Campus S, Origa R.

Expert Opin Drug Metab Toxicol. 2012 Jan;8(1):123-34. doi: 10.1517/17425255.2012.640674. Epub 2011 Dec 19. Review.

PMID:
22176640
38.

Responsiveness to oral iron and ascorbic acid in a patient with IRIDA.

Cau M, Galanello R, Giagu N, Melis MA.

Blood Cells Mol Dis. 2012 Feb 15;48(2):121-3. doi: 10.1016/j.bcmd.2011.11.007. Epub 2011 Dec 14.

PMID:
22169218
39.

Delayed fetal hemoglobin switching in subjects with KLF1 gene mutation.

Satta S, Perseu L, Maccioni L, Giagu N, Galanello R.

Blood Cells Mol Dis. 2012 Jan 15;48(1):22-4. doi: 10.1016/j.bcmd.2011.10.003. Epub 2011 Nov 16.

PMID:
22093801
40.

Structural and Functional Characterization of a New Double Variant Haemoglobin (HbG-Philadelphia/Duarte α(2)β(2)).

Fais A, Casu M, Ruggerone P, Ceccarelli M, Porcu S, Era B, Anedda R, Sollaino MC, Galanello R, Corda M.

ISRN Hematol. 2011;2011:735314. doi: 10.5402/2011/735314. Epub 2010 Nov 29.

41.

Beta-thalassemia: from genotype to phenotype.

Danjou F, Anni F, Galanello R.

Haematologica. 2011 Nov;96(11):1573-5. doi: 10.3324/haematol.2011.055962. No abstract available.

42.

Changing patterns of splenectomy in transfusion-dependent thalassemia patients.

Piga A, Serra M, Longo F, Forni G, Quarta G, Cappellini MD, Galanello R.

Am J Hematol. 2011 Sep;86(9):808-10. doi: 10.1002/ajh.22102. No abstract available.

43.

KLF1 gene mutations cause borderline HbA(2).

Perseu L, Satta S, Moi P, Demartis FR, Manunza L, Sollaino MC, Barella S, Cao A, Galanello R.

Blood. 2011 Oct 20;118(16):4454-8. doi: 10.1182/blood-2011-04-345736. Epub 2011 Aug 5.

44.

A pilot trial of deferiprone for neurodegeneration with brain iron accumulation.

Abbruzzese G, Cossu G, Balocco M, Marchese R, Murgia D, Melis M, Galanello R, Barella S, Matta G, Ruffinengo U, Bonuccelli U, Forni GL.

Haematologica. 2011 Nov;96(11):1708-11. doi: 10.3324/haematol.2011.043018. Epub 2011 Jul 26.

45.

Recent advances in β-thalassemias.

Cao A, Moi P, Galanello R.

Pediatr Rep. 2011 Jun 16;3(2):e17. doi: 10.4081/pr.2011.e17.

46.

Two atypical forms of HbH disease in Sardinia.

Paglietti ME, Sollaino MC, Loi D, Sarra F, Zaccheddu E, Galanello R.

Haematologica. 2011 Nov;96(11):1733-4. doi: 10.3324/haematol.2011.048900. Epub 2011 Jul 12. No abstract available.

47.

Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload.

Smith GC, Alpendurada F, Carpenter JP, Alam MH, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Westwood MA, Galanello R, Roughton M, Pennell DJ.

J Cardiovasc Magn Reson. 2011 Jul 6;13:34. doi: 10.1186/1532-429X-13-34.

48.

Pathophysiology of beta thalassaemia.

Origa R, Galanello R.

Pediatr Endocrinol Rev. 2011 Mar;8 Suppl 2:263-70. Review.

PMID:
21705976
49.

On T2* magnetic resonance and cardiac iron.

Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, Sheppard MN, Porter JB, Walker JM, Wood JC, Galanello R, Forni G, Catani G, Matta G, Fucharoen S, Fleming A, House MJ, Black G, Firmin DN, St Pierre TG, Pennell DJ.

Circulation. 2011 Apr 12;123(14):1519-28. doi: 10.1161/CIRCULATIONAHA.110.007641. Epub 2011 Mar 28.

50.

Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach.

Giardine B, Borg J, Higgs DR, Peterson KR, Philipsen S, Maglott D, Singleton BK, Anstee DJ, Basak AN, Clark B, Costa FC, Faustino P, Fedosyuk H, Felice AE, Francina A, Galanello R, Gallivan MV, Georgitsi M, Gibbons RJ, Giordano PC, Harteveld CL, Hoyer JD, Jarvis M, Joly P, Kanavakis E, Kollia P, Menzel S, Miller W, Moradkhani K, Old J, Papachatzopoulou A, Papadakis MN, Papadopoulos P, Pavlovic S, Perseu L, Radmilovic M, Riemer C, Satta S, Schrijver I, Stojiljkovic M, Thein SL, Traeger-Synodinos J, Tully R, Wada T, Waye JS, Wiemann C, Zukic B, Chui DH, Wajcman H, Hardison RC, Patrinos GP.

Nat Genet. 2011 Mar 20;43(4):295-301. doi: 10.1038/ng.785.

Supplemental Content

Loading ...
Support Center